Skip to the answer
Gyna

Male fertility

What should the male partner do to assess and support sperm quality?

The short answer

  • Fertility concerns? Arrange assessment alongside your partner, including a semen analysis.
  • An abnormal result? Ask about interpretation and repeat testing. One result doesn't settle your fertility.
  • Want to make changes? Stop smoking, reduce alcohol and discuss relevant medicines, supplements or exposures with your clinician.

Supplements aren't a proven shortcut to a live birth. Don't delay assessment while trying to improve a sperm number.

Evidence limits shown Sources are linked. Not yet reviewed by a clinician.

Our public fertility answers link to the sources behind them. If an answer has been reviewed by a clinician, that will be noted on the page. See how we check answers.

What can I do with this?

The first useful action is to include the male partner in the assessment rather than waiting for the other partner to finish every test. At the appointment, ask what the semen result does and doesn't explain, whether it needs repeating, and whether the history or result suggests a specialist review. A laboratory number is information to interpret, not a personal score to keep trying to optimize on your own.

For everyday changes, NHS advice includes stopping smoking, reducing alcohol, avoiding recreational drugs such as anabolic steroids, and considering relevant workplace exposures. These are general-health recommendations, not a guaranteed live-birth treatment. If a medicine, supplement or exposure concerns you, bring its details to the clinician rather than assuming it caused the result or changing prescribed treatment yourself.

If someone recommends a fertility supplement, ask which outcome supports the recommendation: sperm measurements, clinical pregnancy, or live birth. Ask whether that evidence describes people with your situation, and what downsides and costs to consider. Those questions are a way to make the decision clearer; they aren't a reason to spend months trying products before getting assessed.

But does this apply to me?

The Cochrane studies involved men experiencing subfertility, many receiving fertility care; the CoQ10 review concerned idiopathic male infertility, where the cause was unexplained. Their average results don't establish a benefit for everyone who produces sperm, someone with a particular diagnosed cause, or every treatment route. They also don't let us select an individual supplement from a single semen measure.

A low sperm count does not rule out natural conception, as the NHS guidance makes clear. Equally, a result within a laboratory's reference range doesn't test every aspect of fertility. Both points matter: an abnormal result isn't hopelessness, and an apparently reassuring result isn't a reason to stop evaluating an ongoing concern.

Care and safety

When should I get more help?

This page cannot diagnose the reason for a result or tell you which treatment to choose. It doesn't recommend hormone treatment, advanced sperm testing, or a supplement regimen. The testing review discusses specialist options, but their presence in a paper doesn't make them appropriate for every reader.

Don't use a repeat-test interval or a supplement course as a new waiting period if assessment is already indicated. Ask your clinician what should happen in parallel and when the result needs review. If you're already receiving fertility treatment, keep the clinic involved in any proposed change. The practical aim is to understand the next clinical decision, not to promise that changing a number will produce a baby.

Understand the answer

So what does this mean for me?

What does the research actually say?

A semen analysis is useful, but it isn't a verdict on whether you can become a parent. The research review available in full describes it as a cornerstone of assessment while explaining its limits. It measures characteristics such as sperm concentration, movement and shape. Those measurements don't directly test every function involved in fertilization, and the result belongs alongside your history and clinical assessment, not in isolation.

Samples can vary, which is one reason an unexpected result may need repeating. The same review cautions against using morphology, or sperm shape, alone to decide a person's fertility. It also discusses more specialized tests, but that isn't a reason to order every available assay. The review is from 2011. We use its explanation of what a semen analysis can and cannot tell you, not its old numerical reference limits as today's cutoffs for your report.

The supplement evidence shows why a better sperm measurement shouldn't automatically be called a better chance of a baby. A 2022 Cochrane review included 90 studies with 10,303 men experiencing subfertility. Only 12 trials, involving 1,283 participants, contributed to the live-birth analysis. Live birth means a baby born alive. That analysis suggested a possible benefit from antioxidants, but the evidence was rated very low certainty. The review illustrated an assumed live-birth chance of 16 in 100 without antioxidants as 17–27 in 100 with them, based on 246 live births among 1,283 couples. That is a study-follow-up illustration, not a monthly chance or personal forecast; the abstract does not specify a common follow-up period. When studies at high risk of bias were excluded, eight trials involving 827 participants no longer showed a clear live-birth benefit.

This doesn't establish that every supplement is ineffective. It does mean a broad promise that antioxidants improve the chance of a baby runs ahead of the evidence. The review covered different products and study populations, and it also found that mild gastrointestinal discomfort, such as stomach or bowel discomfort, may be more common with antioxidants. Its illustration moves an assumed 2 in 100 without antioxidants to 2–7 in 100 with them, based on 46 events among 1,355 men in 16 trials. The evidence was uncertain and events were few. This is not an individual risk estimate. A supplement isn't automatically free of downsides because it is sold for fertility.

A newer, 2025 review of coenzyme Q10 (CoQ10) found more favorable results. Its nine studies included 781 participants and reported improvements in semen measures and clinical pregnancy, meaning a clinically confirmed pregnancy. The clinical-pregnancy estimate had a wide confidence interval, and the abstract doesn't give us the number of studies or pregnancy events behind that particular outcome. It doesn't report a live-birth result. We shouldn't ignore that positive finding, but neither can we turn it into a reliable absolute benefit, a dose for you, or proof that CoQ10 will help you have a baby. The newer and broader reviews ask different questions; their findings aren't interchangeable.

How does this compare with the official guidance?

NHS guidance puts assessment ahead of guessing from symptoms or buying a supplement. It says both partners should be tested when there are fertility concerns. A semen analysis looks at the amount of sperm, their movement and shape. If the result suggests a possible problem, the NHS describes another test, usually around three months later, and specialist assessment if a problem persists.

That repeat-test interval describes a pathway, not a requirement to postpone an appointment already recommended for you. The NHS advises seeking help after a year of trying, or after six months if the partner trying to become pregnant is 36 or older. Its broader infertility guidance advises earlier help for a known concern. These are NHS thresholds, not a new universal timetable. If you're already in care, your clinic should tell you how testing fits the treatment plan.

Why is this our answer?

This answer draws on a full research review about semen testing, two supplement-review abstracts and two full captured NHS pages. The testing review is older, so we haven't reused its numerical laboratory thresholds.

The supplement papers are available to us only as abstracts. Two independent AI reviewers checked source fidelity and translation; no clinician has reviewed this answer.

Sources for each main claim

What could change the answer?

Interpret semen results with clinical context; low count does not rule out natural conception, and a single apparently normal measure does not settle all fertility questions.

Where is the evidence clear or mixed?

Promising CoQ10 semen/clinical-pregnancy findings do not resolve the broader very-uncertain live-birth evidence. Different endpoints, products and populations matter.

What else are you wondering?

Explore all male fertility questions

Check the evidence

How sure can I be?

See the full evidence snapshot and sources

Evidence snapshot

The same fields appear on every Gyna answer, including when the research did not report something reliably.

Question and decision
How should the male partner arrange assessment and support sperm quality? Explain initial testing and evidence limits, not diagnose or prescribe treatment.
Who was studied
Semen-assessment literature and subfertile men, including fertility-care populations; CoQ10 review concerns idiopathic male infertility.
What was compared
Semen testing is assessment, not treatment. Antioxidant/CoQ10 studies use varied regimens and comparators; no individual dose or product recommended.
Outcome measured, and over what period
Sperm concentration, movement and morphology differ from clinical pregnancy and live birth. No common treatment horizon or individual absolute benefit established here.
Kinds of evidence included
Tier C: one full narrative testing review and two supplement-review abstracts. Tier B: two full captured NHS patient-guidance pages.
Studies and participants
Cochrane: 90 studies/10,303 men; live birth in 12 trials/1,283, or eight/827 excluding high-bias studies. CoQ10: nine studies/781. Review populations must not be summed.
What the evidence shows
An odds ratio (OR) compares group odds, not absolute chances. Cochrane live birth OR 1.43 (95% CI 1.07–1.91), very low certainty; excluding high-bias studies OR 1.22 (0.85–1.75). Review illustration: assumed 16% without antioxidants to 17–27% with them, based on 246 births/1,283 couples over study follow-up, not a monthly or personal forecast. CoQ10 clinical pregnancy OR 6.02 (1.97–18.41), with pregnancy-specific denominators unavailable in the abstract.
Consistency and disagreement
Promising CoQ10 semen/clinical-pregnancy findings do not resolve the broader very-uncertain live-birth evidence. Different endpoints, products and populations matter.
Confidence in this answer
No proven supplement shortcut to live birth. Cochrane live-birth certainty very low; full CoQ10 methods and absolute pregnancy benefit not available here.
Strength of the sources
Foundational testing review is full text but from 2011; old cutoffs excluded. Modern supplement reviews are abstract-only; NHS guidance places the care pathway.
Review status
Sources are linked. Not yet reviewed by a clinician.
Who this does and does not describe
Interpret semen results with clinical context; low count does not rule out natural conception, and a single apparently normal measure does not settle all fertility questions.
Harms, trade-offs and when to seek care
Antioxidants may increase mild gastrointestinal discomfort: assumed 2% without them to 2–7% with them in the review illustration, 46 events/1,355 men in 16 trials; uncertain evidence, not individual risk. No medicine changes, advanced-test or supplement prescription; do not delay indicated partner assessment.
Last searched, and the records behind this
Last evidence search 2026-09-07. The source links are listed below.

Sources

Open the original guidance or study rather than taking our summary on trust.

  1. Semen analysis and sperm function tests: How much to test?

    pmc.ncbi.nlm.nih.gov

  2. Antioxidants for male subfertility

    Cochrane Database of Systematic Reviews · 2022

  3. Efficacy and Safety of Coenzyme Q10 in Idiopathic Male Infertility: A Systematic Review and Meta-Analysis of Randomized Trials

    World J Mens Health · 2025

  4. Low sperm count

    NHS · Page last reviewed 26 January 2024

  5. Infertility

    NHS · Page last reviewed 9 August 2023

How we looked, and what we found

Three results often get merged in supplement claims. A semen measurement describes the sample; clinical pregnancy is a reproductive outcome; live birth is a later, different outcome.

A study can improve the first without establishing either of the others. In the Cochrane review, only a minority of trials contributed live-birth evidence, and that evidence was very uncertain.

That distinction is worth keeping beside any promising result, rather than hiding it after a product recommendation.

Who wrote this, and when will we revisit it?

Drafted from the Gyna internal research library, searched September 7, 2026, with records pinned to the September 2 catalog. Review status: AI source-fidelity and translation checks complete; clinical and human comprehension review pending.

Sources are linked to the claims they support. Current guideline detail and full supplement-trial methods remain evidence gaps; no clinical review is implied by the source list.

Last evidence search
2026-09-07
Last updated
2026-09-08

Our public fertility answers link to the sources behind them. If an answer has been reviewed by a clinician, that will be noted on the page.

Tell us something here is wrong